Orchestra BioMed Holdings (OBIO) Retained Earnings: 2022-2025
Historic Retained Earnings for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Sep 2025 value amounting to -$368.8 million.
- Orchestra BioMed Holdings' Retained Earnings fell 25.57% to -$368.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$368.8 million, marking a year-over-year decrease of 25.57%. This contributed to the annual value of -$309.9 million for FY2024, which is 24.52% down from last year.
- As of Q3 2025, Orchestra BioMed Holdings' Retained Earnings stood at -$368.8 million, which was down 5.98% from -$348.0 million recorded in Q2 2025.
- Over the past 5 years, Orchestra BioMed Holdings' Retained Earnings peaked at -$4.4 million during Q1 2022, and registered a low of -$368.8 million during Q3 2025.
- In the last 3 years, Orchestra BioMed Holdings' Retained Earnings had a median value of -$278.3 million in 2024 and averaged -$282.5 million.
- Data for Orchestra BioMed Holdings' Retained Earnings shows a maximum YoY crashed of 4,709.80% (in 2023) over the last 5 years.
- Quarterly analysis of 4 years shows Orchestra BioMed Holdings' Retained Earnings stood at -$199.7 million in 2022, then fell by 24.59% to -$248.9 million in 2023, then fell by 24.52% to -$309.9 million in 2024, then dropped by 25.57% to -$368.8 million in 2025.
- Its Retained Earnings was -$368.8 million in Q3 2025, compared to -$348.0 million in Q2 2025 and -$328.6 million in Q1 2025.